Literature DB >> 9174138

Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma.

T Kageshita1, T Naruse, S Hirai, T Ono, T Horikoshi, H Nakagawa, K Tamaki, K Hayashibe, M Ichihashi, J Nakayama, Y Hori, A Ozawa, M Miyahara, M Ohkido, H Inoko.   

Abstract

Distribution of HLA-DQA, -DQB and -DPB alleles in ninety-six Japanese patients with melanoma was analyzed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method, and the association between clinical parameters and the presence of certain HLA class II alleles investigated. The frequency of HLA-DQB1*0302 was increased, while those of DQA1*0101(04), -DQA1*0401 and DRB1*0802 were decreased in melanoma patients compared with controls. Moreover, the frequency of HLA-DQA1*0103 in patients with acral lentiginous melanoma was increased compared with controls. However, none of these HLA class II alleles showed significant positive or negative associations after correction of the P value. In addition, there was no correlation between these antigens and clinical parameters. These results indicate that HLA class II alleles may not contribute to a strong susceptibility to melanoma in the Japanese.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174138     DOI: 10.1111/j.1399-0039.1997.tb02780.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

2.  Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors.

Authors:  Tomoko Kobayashi; Shintaro Iwama; Daisuke Sugiyama; Yoshinori Yasuda; Takayuki Okuji; Masaaki Ito; Sachiko Ito; Mariko Sugiyama; Takeshi Onoue; Hiroshi Takagi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Ryoichi Banno; Hiroyoshi Nishikawa; Hiroshi Arima
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

3.  Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.

Authors:  Alexander J Stratigos; Paola Ghiorzo; Kevin M Brown; Susana Puig; Eduardo Nagore; Maria Teresa Landi; D Timothy Bishop; Stuart MacGregor; Mitchell J Machiela; Myriam Brossard; Donato Calista; Jiyeon Choi; Maria Concetta Fargnoli; Tongwu Zhang; Monica Rodolfo; Adam J Trower; Chiara Menin; Jacobo Martinez; Andreas Hadjisavvas; Lei Song; Irene Stefanaki; Richard Scolyer; Rose Yang; Alisa M Goldstein; Miriam Potrony; Katerina P Kypreou; Lorenza Pastorino; Paola Queirolo; Cristina Pellegrini; Laura Cattaneo; Matthew Zawistowski; Pol Gimenez-Xavier; Arantxa Rodriguez; Lisa Elefanti; Siranoush Manoukian; Licia Rivoltini; Blair H Smith; Maria A Loizidou; Laura Del Regno; Daniela Massi; Mario Mandala; Kiarash Khosrotehrani; Lars A Akslen; Christopher I Amos; Per A Andresen; Marie-Françoise Avril; Esther Azizi; H Peter Soyer; Veronique Bataille; Bruna Dalmasso; Lisa M Bowdler; Kathryn P Burdon; Wei V Chen; Veryan Codd; Jamie E Craig; Tadeusz Dębniak; Mario Falchi; Shenying Fang; Eitan Friedman; Sarah Simi; Pilar Galan; Zaida Garcia-Casado; Elizabeth M Gillanders; Scott Gordon; Adele Green; Nelleke A Gruis; Johan Hansson; Mark Harland; Jessica Harris; Per Helsing; Anjali Henders; Marko Hočevar; Veronica Höiom; David Hunter; Christian Ingvar; Rajiv Kumar; Julie Lang; G Mark Lathrop; Jeffrey E Lee; Xin Li; Jan Lubiński; Rona M Mackie; Maryrose Malt; Josep Malvehy; Kerrie McAloney; Hamida Mohamdi; Anders Molven; Eric K Moses; Rachel E Neale; Srdjan Novaković; Dale R Nyholt; Håkan Olsson; Nicholas Orr; Lars G Fritsche; Joan Anton Puig-Butille; Abrar A Qureshi; Graham L Radford-Smith; Juliette Randerson-Moor; Celia Requena; Casey Rowe; Nilesh J Samani; Marianna Sanna; Dirk Schadendorf; Hans-Joachim Schulze; Lisa A Simms; Mark Smithers; Fengju Song; Anthony J Swerdlow; Nienke van der Stoep; Nicole A Kukutsch; Alessia Visconti; Leanne Wallace; Sarah V Ward; Lawrie Wheeler; Richard A Sturm; Amy Hutchinson; Kristine Jones; Michael Malasky; Aurelie Vogt; Weiyin Zhou; Karen A Pooley; David E Elder; Jiali Han; Belynda Hicks; Nicholas K Hayward; Peter A Kanetsky; Chad Brummett; Grant W Montgomery; Catherine M Olsen; Caroline Hayward; Alison M Dunning; Nicholas G Martin; Evangelos Evangelou; Graham J Mann; Georgina Long; Paul D P Pharoah; Douglas F Easton; Jennifer H Barrett; Anne E Cust; Goncalo Abecasis; David L Duffy; David C Whiteman; Helen Gogas; Arcangela De Nicolo; Margaret A Tucker; Julia A Newton-Bishop; Ketty Peris; Stephen J Chanock; Florence Demenais; Jianxin Shi; Mark M Iles; Matthew H Law
Journal:  Nat Genet       Date:  2020-04-27       Impact factor: 38.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.